Iben Lyskjær - Concepedia

Author

Iben Lyskjær

University College London ORCID

Also Known As

I. Lyskjær, Iben Lyskjær, Lyskjær, Iben

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University College London Royal National Orthopaedic Hospital Aarhus University Hospital Heidelberg University CRUK Lung Cancer Centre of Excellence

About

Iben Lyskjær is an author at University College London specializing in tumor biology, molecular diagnostics, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	34
2	Medicine	1	1	34
3	Cell Biology	1	1	34
4	Pathology	1	1	34
5	Cancer Genetics	1	1	34

Iben Lyskjær

Publications

Citations

H-Index

Page 1

	Year	Citations
Sarcoma classification by DNA methylation profiling Christian Koelsche, Daniel Schrimpf, Damian Stichel, Nature Communications	2021	512
miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells Mads H. Rasmussen, Iben Lyskjær, Rosa Jersie-Christensen, Nature Communications	2016	91
<scp>DNA</scp> methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘<scp>DKFZ</scp> Sarcoma Classifier’ Iben Lyskjær, Solange De Noon, Roberto Tirabosco, The Journal of Pathology Clinical Research	2021	58
A genetically inducible porcine model of intestinal cancer Morten M. Callesen, Sigrid S. Árnadóttir, Iben Lyskjær, Molecular Oncology	2017	40
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer Iben Lyskjær, Camilla Kronborg, Mads H. Rasmussen, Scientific Reports	2019	38
Drivers underpinning the malignant transformation of giant cell tumour of bone Matthew W. Fittall, Iben Lyskjær, Peter Ellery, The Journal of Pathology	2020	36
<scp>H3K27me3</scp> expression and methylation status in histological variants of malignant peripheral nerve sheath tumours Iben Lyskjær, Daniel Lindsay, Roberto Tirabosco, The Journal of Pathology Histone ModificationsClassical MpnstsEngineeringEpigenetic ChangeGenetics	2020	34
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, BMC Cancer	2024	34
<scp><i>MYC</i></scp> amplifications are common events in childhood osteosarcoma Solange De Noon, Jannat Ijaz, Tim Coorens, The Journal of Pathology Clinical Research	2021	29
Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA Iben Lyskjær, N. Kara, Solange De Noon, European Journal of Cancer	2022	29

Page 1